Holen Sie sich die Stockscreener-App
1.295
6.52%
-0.085
Schlusskurs vom Vortag:
$1.38
Offen:
$1.35
24-Stunden-Volumen:
850.71K
Relative Volume:
0.30
Marktkapitalisierung:
$92.09M
Einnahmen:
$391.70K
Nettoeinkommen (Verlust:
$-52.34M
KGV:
-1.7267
EPS:
-0.75
Netto-Cashflow:
$-45.92M
1W Leistung:
-13.42%
1M Leistung:
-29.89%
6M Leistung:
+298.64%
1J Leistung:
+9.32%
1-Tages-Spanne:
$1.275
$1.35
1-Wochen-Bereich:
$1.275
$1.53
52-Wochen-Spanne:
$0.2425
$2.01
Ovid Therapeutics Inc Stock (OVID) Company Profile
Firmenname
Ovid Therapeutics Inc
Sektor
Branche
Telefon
212-776-4381
Adresse
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Vergleichen Sie OVID mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OVID
Ovid Therapeutics Inc
|
1.295 | 98.13M | 391.70K | -52.34M | -45.92M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.74 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.23 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.92 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.63 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.82 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-09 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-08 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-06-18 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-04-30 | Eingeleitet | B. Riley Securities | Buy |
| 2024-04-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-05 | Eingeleitet | Wedbush | Outperform |
| 2023-12-21 | Eingeleitet | BTIG Research | Buy |
| 2023-10-13 | Eingeleitet | Oppenheimer | Outperform |
| 2021-04-20 | Herabstufung | Cantor Fitzgerald | Buy → Neutral |
| 2021-03-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-04-20 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Ovid Therapeutics Inc Aktie (OVID) Neueste Nachrichten
Regression analysis insights on Ovid Therapeutics Inc. performanceWeekly Trade Review & Safe Entry Trade Signal Reports - newser.com
Long term hold vs stop loss in Ovid Therapeutics Inc.CEO Change & AI Driven Price Predictions - newser.com
Visual analytics tools that track Ovid Therapeutics Inc. performance2025 Market Overview & Safe Entry Momentum Stock Tips - newser.com
Can trapped investors hope for a rebound in Ovid Therapeutics Inc.Market Weekly Review & Daily Volume Surge Signals - newser.com
Visual trend scoring systems applied to Ovid Therapeutics Inc.Insider Selling & Technical Pattern Based Buy Signals - newser.com
How Ovid Therapeutics Inc. (1OT) stock correlates with oil marketsJuly 2025 Intraday Action & AI Driven Stock Movement Reports - newser.com
Using flow based indicators on Ovid Therapeutics Inc.Trade Entry Report & Verified Swing Trading Watchlist - newser.com
What MACD trends signal for Ovid Therapeutics Inc. (1OT) stockQuarterly Growth Report & Capital Efficient Trading Techniques - newser.com
What analysts say about Ovid Therapeutics Inc 1OT stockSector Leadership Analysis & Low Risk Capital Appreciation - earlytimes.in
Combining machine learning predictions for Ovid Therapeutics Inc.Watch List & Technical Buy Zone Confirmation - newser.com
Is Ovid Therapeutics Inc. stock a safe haven assetWeekly Gains Summary & Scalable Portfolio Growth Methods - newser.com
Is Ovid Therapeutics Inc. (1OT) stock protected from inflation2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
How strong is Ovid Therapeutics Inc. stock balance sheetJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Short Interest in Ovid Therapeutics (NASDAQ:OVID) Grows By 463.2% - MarketBeat
Ovid Therapeutics (OVID) Price Target Increased by 22.06% to 4.23 - Nasdaq
Quarterly Recap: How Ovid Therapeutics Inc. stock compares to industry benchmarksEarnings Summary Report & Weekly Sector Rotation Insights - fcp.pa.gov.br
OVID PRE 14A: approvals for Series B conversion and warrants - Stock Titan
Ovid Therapeutics Raises $175 Million Through PIPE Financing - Finimize
OVID special meeting to approve PIPE share issuances and 315M authorization - Stock Titan
Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ovid Therapeutics Inc-Aktie (OVID) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rona Jeffrey A | CBFO |
Feb 26 '25 |
Sale |
0.56 |
3,902 |
2,185 |
67,973 |
| ALEXANDER MARGARET A. | President and COO |
Jan 27 '25 |
Buy |
0.73 |
6,810 |
4,971 |
34,935 |
1.71%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):